Skip to content

Cefixime

DRUG17 trials

Sponsors

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca, Assistance Publique Hopitaux De Paris, Vion Pharmaceuticals, Children's Hospital Los Angeles, Children's Hospital Medical Center, Cincinnati

Conditions

Acute bacterial prostatitisCervicitisChronic Kidney DiseaseDiarrheaDrug/Agent Toxicity by Tissue/OrganGonococcal InfectionGonorrheaGonorrhea Male

Phase 1

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
CompletedNCT00004216
Vion PharmaceuticalsUnspecified Adult Solid Tumor, Protocol Specific
Start: 1999-08-31End: 2008-01-31Updated: 2013-07-18
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
CompletedNCT00093353
Children's Hospital Los AngelesDiarrhea, Drug/Agent Toxicity by Tissue/Organ, Neuroblastoma
Start: 2004-05-31Target: 30Updated: 2010-10-15
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
CompletedNCT00786669
Children's Hospital Medical Center, CincinnatiSolid Tumor
Start: 2008-10-31End: 2012-11-30Updated: 2021-02-10
The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
CompletedNCT01949363
National Institute of Allergy and Infectious Diseases (NIAID)Gonorrhoea
Start: 2013-12-31End: 2015-12-31Updated: 2019-01-17
A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
CompletedNCT02596503
University of Colorado, DenverRefractory Solid Tumors, Relapsed Solid Tumors
Start: 2015-10-21End: 2020-01-24Updated: 2022-02-15
Cefixime / Azithromycin pK Study
CompletedNCT02708992
National Institute of Allergy and Infectious Diseases (NIAID)Gonorrhoea
Start: 2016-04-28End: 2017-07-31Updated: 2017-09-15
Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women
NCT03752112
World Health OrganizationSyphilis Female
Start: 2019-11-22End: 2021-09-30Target: 180Updated: 2020-02-05
Experimental Human Infection With Neisseria Gonorrhoeae
CompletedNCT03840811
National Institute of Allergy and Infectious Diseases (NIAID)Gonococcal Infection
Start: 2017-04-23End: 2019-11-25Updated: 2021-03-23

Phase 2

Phase 3

Phase 4

Related Papers

Clinical Infectious Diseases2021-02-2527 citations